The diagnostic odyssey: insights from parents of children living with an undiagnosed condition

Abstract

Background People living with rare disease often have protracted journeys towards diagnosis. In the last decade, programs have arisen around the world that are dedicated to ending this ‘diagnostic odyssey’, including the Undiagnosed Diseases Program Western Australia (UDP-WA), which has a focus on finding diagnoses for children and young adults. To explore the lived experience of the diagnostic journey semi-structured interviews were conducted with parents of 11 children at commencement of their involvement in the UDP-WA. Results Thematic analysis revealed three main themes that captured parents’ experiences and perspectives. Parents reported (i) the need to respond to significant care needs of their children, which span not only the health system but other systems such as education and disability services. In doing so, parents become the navigator, expert and advocate for their children. Meanwhile, parents are on (ii) the diagnostic odyssey—the rollercoaster of their journey towards diagnosis, which includes various names applied to their child’s condition, and the impact of no diagnosis. Parents described their views on (iii) the value of a diagnosis and the outcomes they expect to be associated with a diagnosis. Conclusion Analysis showed an overall significant perceived value of a diagnosis. Our study provides new perspectives on the concept of diagnosis and indicates that parents may benefit from supports for their child’s care needs that are beyond the scope of the UDP-WA.

Undiagnosed diseases: Needs and opportunities in 20 countries participating in the Undiagnosed Diseases Network International

“…A key difference among countries seems to be the percentage of the population that lacks appropriate access to diagnostic services; see "Limited availability of genetics testing" (Table 2) (25,26). Beyond the specific RD aspects, this may also reflect the general development differences embodied by allocated and sustainable funding and the capacity of the countries to develop regulations and policies targeted to the unmet diagnostic needs.…”

The Deubiquitinating Enzyme USP48 Interacts with the Retinal Degeneration-Associated Proteins UNC119a and ARL3

“…As such, mutations in genes encoding DUB enzymes have been identified as causative of IRDs and ciliopathies (with or without retinal involvement) [ 16 , 17 , 18 , 20 ]. However, as happens with other rare diseases, there are still patients without a positive genetic diagnosis and the waiting time to reach diagnosis can exceed half a decade [ 48 ]. Many unsolved cases require the identification of novel causative genes and mutations.…”

Epigenomic Approaches for the Diagnosis of Rare Diseases

“…Patients affected by rare diseases can spend an average of 5 years looking for a diagnosis [ 4 ]. Initially, patients are tested for the most common genetic alterations that match their symptoms.…”

“…More than 8000 rare diseases have been described [ 3 ]. The large variabilities and complexities of symptoms often complicate their diagnoses, which can take up to several years for some patients [ 4 ]. Many rare diseases are associated with epigenetic alterations that cause changes in gene expression and can be used to aid diagnosis [ 5 ].…”